Mr. Speaker, I would like to thank my colleague for her excellent speech, and I would also like to give her some new information.
Just before the holidays, I spoke to the Standing Committee on Health, on which I sit, about harm reduction, which is part of the government’s national anti-drug strategy. The InSite supervised injection site contributes to harm reduction.
I asked people from the Canadian Nurses Association, the College of Family Physicians of Canada and the Canadian Medical Association if they thought that harm reduction, which includes supervised injection sites, should be part of the government's national anti-drug strategy. This was the case in the past, before the Conservatives changed tack and eliminated this fourth pillar of Canada’s anti-drug strategy. They all said that we should keep harm reduction in Canada’s anti-drug policy.
Does my colleague also believe that we should integrate harm reduction, to which InSite contributes, into Canada’s national anti-drug policy?